Peer-influenced content. Sources you trust. No registration required. This is HCN.
Endocrinology Advisor
Gepotidacin demonstrated superiority to nitrofurantoin in the EAGLE-3 trial with a therapeutic success rate of 58.9% versus 44%, while maintaining a manageable side effect profile primarily consisting of gastrointestinal disturbances.
Family Medicine/General Practice May 7th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS